Using Alation to Accelerate Your Active Data Governance

whitePaper | June 24, 2022

The reactive approach to discovering, analyzing, and correcting data quality issues in business applications has been marginally effective throughout the era of data consolidation for analytics (data warehousing, etc.) and the subsequent onset of “big data.”

whitePaper | December 1, 2022

We live in an era of connection and the consumer marketplace is no exception. Businesses are expected to not just meet the needs of customers, but anticipate and exceed them.

whitePaper | December 27, 2022

The 2022 data industry white paper consists of five parts. Part 1 discusses data sharing between individuals, across countries and within companies, under this year's theme of 'Data Sharing.' Part 2 summarizes the major policies, legislation, and systems related to the data industry in Korea and abroad. Part 3 deals with the current status of Korean and global data industry markets. In Part 4, the status of each industry based on business data is examined. Part 5 reviews technologies related to data sharing and utilization. Overall, this white paper uses infographics to summarize the flow of related policies, legislations, and institutions that have been promoted over five years, and highlights the main data issues experienced in Korea this year based on data analysis.

whitePaper | October 20, 2022

Data governance defines how data should be gathered and used within an organization. Download this whitepaper to understand how it's linked to business success.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | September 1, 2022

Organizations often adopt a hybrid cloud strategy when deploying their first analytical solution to the cloud. The cloud combines sheer infinite scalability with consumption-based pricing. These are desirable attributes for analytical environments that require scalability and can be very expensive when scaled for maximum capacity over an extended period.